Biotechnology Industries Ltd. Clal serves as Executive at BIOCANCELL THERAPEUTICS INC., where they oversee executive responsibilities. Since joining the company, Biotechnology Industries Ltd. Clal has executed 2 insider transactions totaling $2.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 31, 2012 involved purchasing 10,731,726 shares valued at $2.4M.
Biotechnology Industries Ltd. Clal currently holds 27,323,134 shares of BIOCANCELL THERAPEUTICS INC. (BICL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Biotechnology Industries Ltd. Clal has been a net buyer of BICL stock. They have purchased $2.4M and sold $0 worth of shares.
Biotechnology Industries Ltd. Clal's most recent insider trade was on Jul 31, 2012, when they purchased 10,731,726 shares at $0.22 per share.
Get notified when new Form 4 filings are submitted
| $0.22 |
| Discretionary |